A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

Clinical trial NCT00623831 · COMPLETED

Trial details

NCT number: NCT00623831
Sponsor: Ludwig Institute for Cancer Research
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Sarcoma Gastrointestinal Stromal Tumor (GIST)Head and Neck Cancer Transitional Cell Carcinoma Prostate Cancer Ovarian Carcinoma Esophageal Cancer Breast Cancer

Start date: 2007-05-01
Primary completion: 2012-05-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.